Ziprasidone augmentation of clozapine in 11 patients

被引：30
作者：
Kaye, NS [1 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2003年 / 64卷 / 02期
关键词：
D O I：
10.4088/JCP.v64n0215b
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 10 条
  • [1] A comparative review of new antipsychotics
    Blin, O
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1999, 44 (03): : 235 - 244
  • [2] Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia
    Kapur, S
    Remington, G
    [J]. ANNUAL REVIEW OF MEDICINE, 2001, 52 : 503 - 517
  • [3] Keck P E Jr, 2001, Expert Opin Pharmacother, V2, P1033
  • [4] *PFIZ PHARM, 2001, GEOD PACK INS
  • [5] PIES R, 2001, INT DRUG THER NEWSL, V36, P9
  • [6] Effect of clozapine-quetiapine combination therapy on weight and glycaemic control - Preliminary findings
    Reinstein, MJ
    Sirotovskaya, LA
    Jones, LE
    Mohan, S
    Chasanov, MA
    [J]. CLINICAL DRUG INVESTIGATION, 1999, 18 (02) : 99 - 104
  • [7] Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile
    Schmidt, AW
    Lebel, LA
    Howard, HR
    Zorn, SH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 425 (03) : 197 - 201
  • [8] Stahl SM, 1999, J CLIN PSYCHIAT, V60, P31
  • [9] Tandon R, 2000, BRIT J CLIN PHARMACO, V49, p1S
  • [10] Atypical antipsychotics and weight gain - a systematic review
    Taylor, DM
    McAskill, R
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2000, 101 (06) : 416 - 432
1